- 8 days & nights inpatient stay
- 1 quick follow-up appointment
Participants will be reimbursed $2,550 for participating in this study and this clinical trial has been approved by an independent ethics committee.
About the study
We need healthy people for a study investigating a potential new treatment for Alzheimer’s disease. Tricaprilin is a medium chain triglyceride (MCT) or specialised lipid that is a potential treatment for the condition. It has been shown to be a simple and safe method of inducing ketone body production and therefore providing an alternative source of energy for the brain instead of glucose.
At this stage of testing we are not looking at whether the medication will have any therapeutic value, so we require healthy people with no medical conditions to participate.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at email@example.com quoting “Cognition Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!